A deletion within the murine Werner syndrome helicase induces sensitivity to inhibitors of topoisomerase and loss of cellular proliferative capacity

被引:239
作者
Lebel, M
Leder, P
机构
[1] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA
[2] Howard Hughes Med Inst, Boston, MA 02115 USA
关键词
D O I
10.1073/pnas.95.22.13097
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Werner syndrome (WS) is an autosomal recessive disorder characterized by genomic instability and the premature onset of a number of age-related diseases. The gene responsible for WS encodes a member of the RecQ-like subfamily of DNA helicases, Here we show that its murine homologue maps to murine chromosome 8 in a region syntenic with the human WRN gene. We have deleted a segment of this gene and created Wrn-deficient embryonic stem (ES) cells and WS mice. While displaying reduced embryonic survival, live-born WS mice otherwise appear normal during their first year of life. Nonetheless, although several DNA repair systems are apparently intact in homozygous WS ES cells, such cells display a higher mutation rate and are significantly more sensitive to topoisomerase inhibitors (especially camptothecin) than are wild-type ES cells. Furthermore, mouse embryo fibroblasts derived from homozygous WS embryos show premature loss of proliferative capacity. At the molecular level, wild-type, but not mutant, WS protein copurifies through a series of centrifugation and chromatography steps with a multiprotein DNA replication complex.
引用
收藏
页码:13097 / 13102
页数:6
相关论文
共 46 条
[1]  
CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V13, P2633
[2]   A GENETIC-LINKAGE MAP OF THE MOUSE - CURRENT APPLICATIONS AND FUTURE-PROSPECTS [J].
COPELAND, NG ;
JENKINS, NA ;
GILBERT, DJ ;
EPPIG, JT ;
MALTAIS, LJ ;
MILLER, JC ;
DIETRICH, WF ;
WEAVER, A ;
LINCOLN, SE ;
STEEN, RG ;
STEIN, LD ;
NADEAU, JH ;
LANDER, ES .
SCIENCE, 1993, 262 (5130) :57-66
[3]   MICE LACKING P21(C/P1/WAF1) UNDERGO NORMAL DEVELOPMENT, BUT ARE DEFECTIVE IN G1 CHECKPOINT CONTROL [J].
DENG, CX ;
ZHANG, PM ;
HARPER, JW ;
ELLEDGE, SJ ;
LEDER, P .
CELL, 1995, 82 (04) :675-684
[4]   Effects of topoisomerase II inhibition in lymphoblasts from patients with progeroid and ''chromosome instability'' syndromes [J].
Elli, R ;
Chessa, L ;
Antonelli, A ;
Petrinelli, P ;
Ambra, R ;
Marcucci, L .
CANCER GENETICS AND CYTOGENETICS, 1996, 87 (02) :112-116
[5]   WERNERS SYNDROME - A REVIEW OF ITS SYMPTOMATOLOGY NATURAL HISTORY PATHOLOGIC FEATURES GENETICS AND RELATIONSHIP TO NATURAL AGING PROCESS [J].
EPSTEIN, CJ ;
MARTIN, GM ;
SCHULTZ, AL ;
MOTULSKY, AG .
MEDICINE, 1966, 45 (03) :177-+
[6]  
FIKUCHI K, 1985, SOMAT CELL MOLEC GEN, V11, P303
[7]  
FUKUCHI K, 1990, HUM GENET, V84, P249
[8]   MUTATOR PHENOTYPE OF WERNER SYNDROME IS CHARACTERIZED BY EXTENSIVE DELETIONS [J].
FUKUCHI, K ;
MARTIN, GM ;
MONNAT, RJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (15) :5893-5897
[9]   THE YEAST TYPE-I TOPOISOMERASE TOP3 INTERACTS WITH SGS1, A DNA HELICASE HOMOLOG - A POTENTIAL EUKARYOTIC REVERSE GYRASE [J].
GANGLOFF, S ;
MCDONALD, JP ;
BENDIXEN, C ;
ARTHUR, L ;
ROTHSTEIN, R .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (12) :8391-8398
[10]   DNA TOPOISOMERASE-I TARGETED CHEMOTHERAPY OF HUMAN-COLON CANCER IN XENOGRAFTS [J].
GIOVANELLA, BC ;
STEHLIN, JS ;
WALL, ME ;
WANI, MC ;
NICHOLAS, AW ;
LIU, LF ;
SILBER, R ;
POTMESIL, M .
SCIENCE, 1989, 246 (4933) :1046-1048